Unicycive Therapeutics, Inc.

NASDAQ:UNCY

0.7692 (USD) • At close June 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Assets:
Current Assets:
Cash & Cash Equivalents 26.1429.7010.45516.57900.0150.025
Short Term Investments 0000000
Cash and Short Term Investments 26.1429.7010.45516.57900.0150.025
Net Receivables 0000000
Inventory 0000000
Other Current Assets 4.8063.6982.1891.8320.2040.0040.004
Total Current Assets 30.94813.3992.64418.4110.2040.0190.029
Non-Current Assets:
Property, Plant & Equipment, Net 0.720.7920.1740.333000
Goodwill 0000000
Intangible Assets 0000000
Goodwill and Intangible Assets 0000000
Long Term Investments 0000000
Tax Assets 0000000
Other Non-Current Assets 00-0.174-0.3330.200
Total Non-Current Assets 0.720.7920.1740.3330.200
Total Assets 31.66814.1912.81818.7440.2040.0190.029
Liabilities & Equity:
Current Liabilities:
Account Payables 0.9660.8210.8460.7130.1840.3220.06
Short Term Debt 0.5640.3450.310.3022.5140.461.047
Tax Payables 0000000
Deferred Revenue 0-0.01800000
Other Current Liabilities 22.49816.3682.1281.090.1770.1210.128
Total Current Liabilities 24.1217.5343.2842.1052.8750.9031.235
Non-Current Liabilities:
Long Term Debt 0.1170.46600.155000
Deferred Revenue Non-Current 0000000
Deferred Tax Liabilities Non-Current 0000000
Other Non-Current Liabilities 0000000
Total Non-Current Liabilities 0.1170.4660.0010.155000
Total Liabilities 24.237183.2842.262.8750.9031.235
Equity:
Preferred Stock 0000000
Common Stock 0.1140.0350.0150.0150.0090.0080.034
Retained Earnings -101.27-64.541-33.997-15.939-5.922-3.658-1.493
Accumulated Other Comprehensive Income/Loss 0000000
Other Total Stockholders Equity 108.58760.69733.51632.4083.2422.7660.253
Total Shareholders Equity 7.431-3.809-0.46616.484-2.671-0.884-1.206
Total Equity 7.431-3.809-0.46616.484-2.671-0.884-1.206
Total Liabilities & Shareholders Equity 31.66814.1912.81818.7440.2040.0190.029